Nabriva Therapeutics plc (55) | Retention Agreements (1)
- Retention Agreement, dated August 5, 2020, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz (Filed With SEC on November 5, 2020)
© 2023 Justia
